Cardiovascular Risk Plummets After Weight-Loss Surgery

The Roux-en-Y procedure significantly lowers risk of heart attack, stroke and kidney disease in individuals struggling with obesity and diabetes.

0
More than 10 randomized clinical trials have shown that bariatric surgery—also called weight-loss surgery or metabolic surgery—improves diabetes control and cardiovascular disease (CVD) risk factors better than the best medications in individuals with obesity and type 2 diabetes mellitus (T2DM). “Glucagon-like peptide-1 receptor (GLP-1) agonists and sodium glucose transporter 2 (SGLT2) inhibitors are among the […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

LEAVE A REPLY

Please enter your comment!
Please enter your name here